Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Equity Transactions - Additional Information (Detail)

v3.8.0.1
Equity Transactions - Additional Information (Detail)
1 Months Ended 12 Months Ended
May 25, 2017
USD ($)
Director
$ / shares
shares
Jul. 28, 2016
USD ($)
Director
$ / shares
shares
Apr. 20, 2016
USD ($)
Director
$ / shares
shares
Dec. 30, 2015
shares
Jun. 16, 2015
USD ($)
Director
$ / shares
shares
Apr. 16, 2015
USD ($)
Director
$ / shares
shares
Aug. 31, 2017
shares
Dec. 31, 2017
$ / shares
shares
Dec. 31, 2016
$ / shares
shares
Dec. 31, 2015
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Temporary equity, shares outstanding               6,864,000 6,600,000  
Restricted Stock [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted               372,711 43,332 11,440
Restricted shares, weighted average fair market value | $ / shares               $ 7.27 $ 8.49 $ 5.08
Restricted Stock [Member] | Independent Directors [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Number of directors | Director 6 6 6   2 4        
Restricted Stock [Member] | Other Executives [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 320,709                  
Restricted Stock [Member] | Director One [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150   1,560 2,080        
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050   $ 9,079 $ 10,025        
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00   $ 5.82 $ 4.82        
Restricted Stock [Member] | Director Two [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150   1,560 2,080        
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050   $ 9,079 $ 10,025        
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00   $ 5.82 $ 4.82        
Restricted Stock [Member] | Director Three [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150     2,080        
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050     $ 10,025        
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00     $ 4.82        
Restricted Stock [Member] | Director Four [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150     2,080        
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050     $ 10,025        
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00     $ 4.82        
Restricted Stock [Member] | Director Five [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150              
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050              
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00              
Restricted Stock [Member] | Director Six [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Restricted common stock granted 8,667 5,072 2,150              
Fair market value restricted common stock | $ $ 63,009 $ 46,257 $ 15,050              
Restricted shares, weighted average fair market value | $ / shares $ 7.27 $ 9.12 $ 7.00              
Clarient, Inc. [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Business acquisition, purchase price payment in share       15,000,000            
Clarient, Inc. [Member] | Payment In Kind Period Two [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Additional preferred stock issued               264,000    
Clarient, Inc. [Member] | Series A Redeemable Convertible Preferred Stock [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Business acquisition, purchase price payment in share       14,666,667            
Temporary equity, number of share redeemed during the period                 8,066,667  
Temporary equity, shares outstanding               6,864,000 6,600,000  
Clarient, Inc. [Member] | Series A Redeemable Convertible Preferred Stock [Member] | Payment In Kind Period Two [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Additional preferred stock issued               264,000    
Ascend Genomics [Member]                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Issuance of restricted stock, shares             450,000      
Restricted stock initial registering and trading restriction period             6 months